Norris Perne & French LLP MI continued to hold its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 2,860 shares of the medical equipment provider’s stock at the end of the second quarter. Norris Perne & French LLP MI’s holdings in Varian Medical Systems were worth $295,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the stock. BlackRock Inc. boosted its stake in shares of Varian Medical Systems by 3,169.5% in the first quarter. BlackRock Inc. now owns 7,899,768 shares of the medical equipment provider’s stock valued at $719,907,000 after buying an additional 7,658,148 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Varian Medical Systems by 318.2% in the first quarter. Wells Fargo & Company MN now owns 1,302,180 shares of the medical equipment provider’s stock valued at $118,667,000 after buying an additional 990,791 shares in the last quarter. FMR LLC boosted its stake in shares of Varian Medical Systems by 324.5% in the first quarter. FMR LLC now owns 1,006,924 shares of the medical equipment provider’s stock valued at $91,760,000 after buying an additional 769,718 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Varian Medical Systems during the first quarter valued at about $32,433,000. Finally, First Eagle Investment Management LLC boosted its stake in shares of Varian Medical Systems by 7.5% in the first quarter. First Eagle Investment Management LLC now owns 4,641,466 shares of the medical equipment provider’s stock valued at $422,977,000 after buying an additional 323,406 shares in the last quarter. Hedge funds and other institutional investors own 99.27% of the company’s stock.

Shares of Varian Medical Systems, Inc. (NYSE:VAR) opened at 96.48 on Tuesday. The company has a 50-day moving average of $103.21 and a 200-day moving average of $92.66. Varian Medical Systems, Inc. has a 52-week low of $75.20 and a 52-week high of $107.08. The stock has a market capitalization of $8.85 billion, a price-to-earnings ratio of 31.76 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.09. The company had revenue of $662.40 million for the quarter, compared to analyst estimates of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. Varian Medical Systems’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.00 EPS. Equities research analysts anticipate that Varian Medical Systems, Inc. will post $3.95 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/08/varian-medical-systems-inc-nysevar-position-maintained-by-norris-perne-french-llp-mi.html.

VAR has been the topic of several recent research reports. Off Wall Street initiated coverage on shares of Varian Medical Systems in a research report on Monday, April 24th. They set a “sell” rating on the stock. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Varian Medical Systems in a research report on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 price objective on the stock. Zacks Investment Research lowered shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, April 28th. BTIG Research raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $106.00 price objective on the stock in a research report on Monday, May 8th. Finally, Citigroup Inc. raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating in a research report on Monday, May 15th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $96.28.

In other news, Director Timothy E. Guertin sold 16,000 shares of the business’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $103.22, for a total value of $1,651,520.00. Following the sale, the director now directly owns 2,161 shares of the company’s stock, valued at approximately $223,058.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark R. Laret sold 1,428 shares of the business’s stock in a transaction that occurred on Thursday, June 8th. The shares were sold at an average price of $103.47, for a total transaction of $147,755.16. Following the completion of the sale, the director now directly owns 3,289 shares in the company, valued at $340,312.83. The disclosure for this sale can be found here. Insiders sold a total of 144,087 shares of company stock worth $14,652,328 over the last three months. Insiders own 0.91% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.